FDA rules against Actavis Wellbutrin generic; Tylenol killer remains free; California gov vetoes biosimilars bill;

@EricPFierce: MHRA says it also took action against Wockhardt contractor Nestor in U.K. as part of recent action. Article | Follow @EricPFierce

> The FDA without fanfare last week ruled that a second generic version of GlaxoSmithKline's ($GSK) Wellbutrin antidepressant, this one from Actavis ($ACT), is not bioequivalent and will be pulled off the market. Story

> Some new assignments by FDA Commissioner Margaret Hamburg are raising questions about how plant inspection negotiations will be handled going forward. Story

> California Gov. Jerry Brown has vetoed a bill that would have restricted biosimilars in the state. Story (sub. req.)

> More than 200 people in Spain born with disabilities they say are tied to thalidomide have sued German drugmaker Gruenthal. Story

> African drugmakers are looking to Ghana to be a hub for manufacturing. Story

And Finally... Three decades after 7 Chicago-area people were poisoned to death when they took Tylenol laced with cyanide, the crime remains unsolved. Story (sub. req.)